Navigation Links
Catholic Health Association Applauds HHS Decision on Plan B
Date:12/9/2011

WASHINGTON, Dec. 9, 2011 /PRNewswire-USNewswire/ -- Sister Carol Keehan, DC, president and chief executive officer of the Catholic Health Association of the United States (CHA), issued the following statement.

The Catholic Health Association is very grateful to HHS Secretary Kathleen Sebelius for her intelligent and courageous decision to prevent very young adolescents from purchasing and administering unsupervised the strong hormone contained in the drug known as Plan B.

There is grave concern about the safety of very young adolescents self-administering this hormone at such a critical time in their growth cycle. This is not a case of politics versus science. There is no strong science that definitively establishes the safety of this drug when self-administered by 11- and 13-year olds. 

CHA has great respect for the FDA, but there are no significant studies in 11 to 13-year olds over a long period of time that have demonstrated the safety of this very significant drug. We do not want to learn in 10 to 20 years about this drug what we now know about hormone replacement therapy and its connection to breast cancer. In addition, there are no long term studies that demonstrate the drug's potential impact on future reproductive choices these young girls will make.

Our country must help parents exercise their responsibility to their children. Giving parents control over relatively inconsequential areas such as ear-piercing and then taking it away in such a serious area would not only put their children at risk but undermine parents' ability to parent. This great country is built on the strength of the family and this decision helps to maintain a strong role for parents in critical decisions. 

The Catholic Health Association of the United States (CHA), founded in 1915, supports the Catholic health ministry's commitment to improve the health status of communities and create quality and compassionate health care that works for everyone. The Catholic health ministry is the nation's largest group of not-for-profit health systems and facilities that, along with their sponsoring organizations, employ more than 750,000 women and men who deliver services combining advanced technology with the Catholic caring tradition. For more information, visit the CHA website at www.chausa.org.


'/>"/>
SOURCE Catholic Health Association of the United States
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
2. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
3. HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
5. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
6. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
7. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. Nicotinic Acid: The Key Ingredient in Niacin Dietary Supplements that Supports Heart Health
10. Verinata Health Announces New Corporate Headquarters and Expanded Laboratory Operations
11. Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... INDIANAPOLIS , Feb. 12, 2016  Eli Lilly and ... High Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent ... in the UK, France , ... instructions to dilute the product only with dextrose solution.  ... of 2015, the UK Court of Appeal held that Lilly,s ...
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
Breaking Medicine Technology:
(Date:2/13/2016)... , ... February 13, 2016 , ... ... of Nursing with an in-kind gift of a VeinViewer® Vision vein finder ... they learn how to start an IV and draw blood, combining technology with ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s ... Buddha, the biography of Rama - Dr. Frederick Lenz. , According to ... of a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose ... – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose ... products, garnering increased attention from all stakeholders in the development of new chemical ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a family owned ... Texas, is launching a cooperative charity drive with the Tarrant Area Food Bank in ... 50,000 individuals and families in need, the Tarrant County Food Bank offers hope and ...
Breaking Medicine News(10 mins):